Get started
HEALTHCARE GLOB. ENT. LTDHEALTHCARE GLOB. ENT. LTDHEALTHCARE GLOB. ENT. LTD

HEALTHCARE GLOB. ENT. LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

HCG chart


Full chart

HCG upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪65.68 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
115.55
Basic EPS (TTM)
4.10 INR
Net income (FY)
‪481.55 M‬ INR
Revenue (FY)
‪19.08 B‬ INR
Shares float
‪31.68 M‬
Beta (1Y)
−0.16

Employees


Employees (FY)
‪6.15 K‬
Change (1Y)
+646 +11.74%
Revenue / Employee (1Y)
‪3.10 M‬ INR
Net income / Employee (1Y)
‪78.30 K‬ INR

About HEALTHCARE GLOB. ENT. LTD


Sector
Health Services
Industry
Hospital/Nursing Management
CEO
Meghraj Arvindrao Gore
Website
hcgoncology.com
Headquarters
Bangalore
Founded
1998
ISIN
INE075I01017
FIGI
BBG00CG8VDK3
HealthCare Global Enterprises Ltd. engages in providing imaging and diagnostics services for cancer treatment. It focuses on maintenance of cancer treatment centers, imaging and diagnostics, and clinical trials and research services. It operates through the India and Outside India geographical segments. The company was founded on March 12, 1998 and is headquartered in Bangalore, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

HCG news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of HCG is 480.65 INR — it has increased by 2.05% in the past 24 hours. Watch HEALTHCARE GLOB. ENT. LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange HEALTHCARE GLOB. ENT. LTD stocks are traded under the ticker HCG.
HCG stock has fallen by −9.80% compared to the previous week, the month change is a −4.70% fall, over the last year HEALTHCARE GLOB. ENT. LTD has showed a 30.93% increase.
We've gathered analysts' opinions on HEALTHCARE GLOB. ENT. LTD future price: according to them, HCG price has a max estimate of 600.00 INR and a min estimate of 525.00 INR. Watch HCG chart and read a more detailed HEALTHCARE GLOB. ENT. LTD stock forecast: see what analysts think of HEALTHCARE GLOB. ENT. LTD and suggest that you do with its stocks.
HCG reached its all-time high on Dec 20, 2024 with the price of 548.00 INR, and its all-time low was 62.05 INR and was reached on Apr 15, 2020. View more price dynamics on HCG chart.
See other stocks reaching their highest and lowest prices.
HCG stock is 3.14% volatile and has beta coefficient of −0.16. Track HEALTHCARE GLOB. ENT. LTD stock price on the chart and check out the list of the most volatile stocks — is HEALTHCARE GLOB. ENT. LTD there?
Today HEALTHCARE GLOB. ENT. LTD has the market capitalization of ‪66.00 B‬, it has decreased by −10.49% over the last week.
Yes, you can track HEALTHCARE GLOB. ENT. LTD financials in yearly and quarterly reports right on TradingView.
HEALTHCARE GLOB. ENT. LTD is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
HCG earnings for the last quarter are 1.30 INR per share, whereas the estimation was 1.58 INR resulting in a −17.72% surprise. The estimated earnings for the next quarter are 0.55 INR per share. See more details about HEALTHCARE GLOB. ENT. LTD earnings.
HEALTHCARE GLOB. ENT. LTD revenue for the last quarter amounts to ‪5.54 B‬ INR, despite the estimated figure of ‪5.70 B‬ INR. In the next quarter, revenue is expected to reach ‪5.82 B‬ INR.
HCG net income for the last quarter is ‪179.90 M‬ INR, while the quarter before that showed ‪120.80 M‬ INR of net income which accounts for 48.92% change. Track more HEALTHCARE GLOB. ENT. LTD financial stats to get the full picture.
No, HCG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has ‪6.15 K‬ employees. See our rating of the largest employees — is HEALTHCARE GLOB. ENT. LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HEALTHCARE GLOB. ENT. LTD EBITDA is ‪3.60 B‬ INR, and current EBITDA margin is 17.20%. See more stats in HEALTHCARE GLOB. ENT. LTD financial statements.
Like other stocks, HCG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEALTHCARE GLOB. ENT. LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HEALTHCARE GLOB. ENT. LTD technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HEALTHCARE GLOB. ENT. LTD stock shows the buy signal. See more of HEALTHCARE GLOB. ENT. LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.